Page 83 - Sohini Das

Covid-19 vaccine pricing accounts for last-mile delivery, say firms

The cost of logistics is built into the final price of the vaccine, especially when supplying to the private sector

Covaxin's final product has no calf serum, Bharat Biotech and govt clarify

Health ministry says this has been used for decades in Polio, Rabies, and Influenza vaccines, is neither used in growth of SARS CoV2 virus nor in the final formulation

Decoded: Delta, Delta Plus variants and their response to vaccines

While virologists say theoretically the vaccine that works on Delta should work on the Delta Plus variant as well, more research is needed

Covid-19 vaccine Covaxin at Rs 150 not sustainable: Bharat Biotech

Higher price in private market required to offset part of the costs, argues firm

Govt panel confirms first death in India after Covid-19 vaccination

68-year-old man was administered Covishield on Mar 8

Novavax Covid-19 shot shows 90% efficacy, Serum Institute starts production

On track to make 100 mn doses per month by Q3 of 2021

Covid-19 drugs portfolio boost domestic sales of companies in FY21

Chronic therapy areas like cardiac and anti-diabetic have maintained their growth rates during FY21 despite a washout in the first quarter

Zydus Cadila may soon seek emergency use authorisation for Covid-19 vaccine

This could also be India's first vaccine for children aged 12 years and above as the company has conducted trials on the age group. The decision, however, lies with the regulator

Covid-19 pandemic: Bharat Biotech's Covaxin set for clinical trials in US

FDA asks Bharat Bio's US partner Ocugen to apply for full authorisation

Bharat Biotech to conduct additional clinical trials for USFDA nod

Timelines will be delayed; firm has received EUSs from 14 other countries

Hospitals grapple with post-Covid admissions, plan to add dedicated ICUs

While post-Covid patients are contributing to the footfall, there is also a pick-up in non-Covid treatment.

Pfizer's Covid-19 vaccine may cost less than $10 a dose in India

Govt likely to give partial indemnity to company

Covaxin Phase-3 efficacy analysis to be made public by July: Bharat Biotech

The company is also doing phase-4 trials for real world effectiveness of the jab

Hyderabad's Rockwell collaborates with Dr Reddy's Lab for Sputnik V rollout

Rockwell Industries has got orders for 750 Covid19 vaccine freezers from hospitals and institutions.

Covid-19 vaccination: Govt books 440 million doses with 30% advance

250 mn Covishield and 190 mn Covaxin doses meant for Aug-Dec period

Study on Covishield, Covaxin antibody response is limited: Bharat Biotech

Raches Ella, project lead, Covid-19 vaccines at the firm says he is surprised that media and researchers are drawing conclusions based on non-peer reviewed work

Hope to launch diabetic NCE by next financial year: Torrent Pharma's Mehta

We would also look into distribution opportunities to bring some of these products into the market, said Mehta

Bharat Biotech, Ocugen extend agreement to market Covaxin in Canada

Phase 3 analysis data to be submitted to WHO soon for EUL

Covid-19 pandemic: Serum Institute seeks indemnity for jab again

In talks with RDIF to manufacture Sputnik V in India

Decoded: Who can get antibody cocktail for Covid-19 and how it works

Used to treat only mild to moderate disease in high-risk Covid-19 patients, doctors feel the treatment can bolster the fight against severe disease